Management of narcolepsy in pregnancy.
Hoover-Stevens
S
S
Department of Neurological Sciences, Rush University/Rush-Presbyterian-St. Luke 's Medical Center, Chicago, Illinois 60612, USA.
Kovacevic-Ristanovic
R
R
D000328:Adult; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000473:pathology; D019052:Depression, Postpartum / Q000188:drug therapy / Q000523:psychology; D003913:Dextroamphetamine / Q000627:therapeutic use; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use; D008895:Milk, Human / Q000378:metabolism; D009290:Narcolepsy / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D010389:Pemoline / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications; D012148:Restless Legs Syndrome / Q000188:drug therapy; D007319:Sleep Initiation and Maintenance Disorders / Q000150:complications / Q000188:drug therapy
D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D010389:Pemoline; D003913:Dextroamphetamine